Sesen Bio Inc.

+0.03 (+8.12%)
Mergers / Acquisitions

Sesen Bio, Carisma Therapeutics Announce Merger Agreement

Published: 09/21/2022 12:54 GMT
Sesen Bio Inc. (SESN) - Sesen Bio and Carisma Therapeutics Announce Merger Agreement.
Sesen Bio Inc - Cash Runway of Combined Company Expected to Enable Multiple Clinical Readouts Across Carisma Programs.
Sesen Bio Inc - Combined Company Expected to Have Approximately $180 Million of Cash, Cash Equivalents and Marketable Securities.
Sesen Bio Inc - Merger and Related Financing Are Expected to Close in Next Three to Four Months.